Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artivion (AORT) Shares Outstanding (2016 - 2025)

Artivion's Shares Outstanding history spans 17 years, with the latest figure at $49.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 13.58% year-over-year to $49.3 million; the TTM value through Dec 2025 reached $49.3 million, up 13.58%, while the annual FY2025 figure was $49.3 million, 13.58% up from the prior year.
  • Shares Outstanding reached $49.3 million in Q4 2025 per AORT's latest filing, up from $48.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $49.3 million in Q4 2025 to a low of $40.6 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $43.2 million, with a median of $42.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: grew 1.05% in 2022, then rose 13.58% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $41.4 million in 2021, then rose by 1.05% to $41.8 million in 2022, then rose by 1.77% to $42.6 million in 2023, then grew by 2.03% to $43.4 million in 2024, then rose by 13.58% to $49.3 million in 2025.
  • Per Business Quant, the three most recent readings for AORT's Shares Outstanding are $49.3 million (Q4 2025), $48.9 million (Q3 2025), and $48.6 million (Q2 2025).